Workflow
Cryo-Cell International(CCEL) - 2023 Q4 - Annual Report

Title of each class Trading Symbol(s) Name of each exchange on which registered ☒ ANNUAL REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. For the fiscal year ended November 30, 2023 ☐ TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. For the transition period from to Commission File Number 001-40767 Washington, D.C. 20549 (Exact Name of registrant as specified in its charter) DELAWARE 22-3023093 (State or other jurisdiction of incorporation or organi ...